Our Pricing

Get Your Fat Jab Prescription Online in the UK

Published on: June 03, 2026

Looking for a fat jab prescription online UK service? At Cured Pharmacy, you can access licensed weight loss injections including Mounjaro, Wegovy, and Saxenda through a free online consultation with UK-registered prescribers. Our transparent pricing starts from £135.00 with all medications dispensed by our GPhC-registered pharmacy and delivered discreetly to your door.

What Are Fat Jabs and How Do They Work?

Fat jabs—clinically known as GLP-1 receptor agonists—are prescription weight loss injections that mimic natural hormones your body produces to regulate appetite and blood sugar. These medications include tirzepatide (Mounjaro), semaglutide (Wegovy), and liraglutide (Saxenda), all licensed by the MHRA for weight management in adults with a BMI of 30 or above, or 27 with weight-related health conditions [1].

GLP-1 medications work by slowing gastric emptying, reducing appetite signals to the brain, and improving insulin sensitivity. In the landmark STEP trials, patients using semaglutide achieved an average body weight reduction of 14.9% over 68 weeks, whilst the SURMOUNT-1 trial demonstrated that tirzepatide produced up to 22.5% average weight loss over 72 weeks [1][2]. These results significantly exceed outcomes from diet and exercise alone.

At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team ensure every prescription is appropriate for your individual circumstances, with ongoing support throughout your weight loss journey.

Comparing Fat Jab Options: Mounjaro, Wegovy, and Saxenda

Choosing the right fat jab depends on your medical history, weight loss goals, and tolerance for injection frequency. Mounjaro (tirzepatide) is the newest option and the first dual GIP/GLP-1 receptor agonist, offering the highest average weight loss in clinical trials. It's administered once weekly via a pre-filled KwikPen.

Wegovy (semaglutide) is also a once-weekly injection that has been available in the UK since 2023. Clinical data shows robust weight loss outcomes, with an average reduction of 15.3% body weight in the STEP 5 trial over 104 weeks [2]. Wegovy is often recommended for patients who prefer a well-established treatment with extensive real-world evidence.

Saxenda (liraglutide) requires daily injections but offers flexibility for patients who prefer more frequent, lower-dose administration. In the SCALE trial, patients achieved an average 8% weight loss over 56 weeks [3]. Your UK prescriber will assess which medication aligns with your lifestyle, medical conditions, and weight management objectives.

Which Fat Jab Is Right for You?

During your free online consultation, our UK prescribers evaluate factors including your current BMI, previous weight loss attempts, cardiovascular health, and any contraindications such as diabetic retinopathy or personal history of thyroid cancer. Patients with type 2 diabetes may benefit from Mounjaro's dual-action mechanism, whilst those seeking established efficacy often choose Wegovy. Saxenda suits individuals who prefer daily control over their dosing schedule.

How to Get Your Fat Jab Prescription Online at Cured Pharmacy

Our streamlined online consultation takes under three minutes to complete. You'll answer questions about your weight history, current medications, and relevant health conditions. A UK-registered prescriber reviews your assessment the same day, and if approved, your prescription is sent directly to our GPhC-registered pharmacy (registration number 9012511).

We dispense only genuine UK-licensed medications sourced from approved wholesalers. Your fat jab is packaged discreetly with no external branding and dispatched via tracked courier. Most patients receive their medication within 2–3 working days, with next-day delivery available in many areas.

Transparent pricing is shown upfront before you complete your consultation—no hidden fees or surprise charges. Our lowest price guarantee ensures you're getting competitive UK pricing on every treatment, and our clinical team remains available by phone ((+44) 116 4646009) for any questions during your treatment.

What Happens After Approval?

Once your prescription is approved, you'll receive an email confirmation with tracking details. Your first delivery includes detailed administration instructions, sharps disposal guidance, and advice on managing potential side effects. We offer ongoing prescription renewals through simple follow-up consultations, ensuring continuity of care without needing to visit a GP surgery.

Fat Jab Pricing and Cost Comparison in the UK

At Cured Pharmacy, Mounjaro starts from £135.00 per month, positioning us among the most competitive providers in the UK market. Pricing varies by prescribed dose—your clinician will start you on the appropriate strength and adjust based on your response and tolerability.

We guarantee the lowest prices in the UK without compromising on clinical standards or medication authenticity. Unlike some providers who advertise low headline prices but add consultation fees, delivery charges, or mandatory subscriptions, our pricing is transparent from the start. You'll see the exact cost before completing your medical assessment.

Private prescriptions for weight loss injections represent a significant investment in your health, but clinical trials demonstrate that even modest weight loss (5–10% of body weight) substantially reduces risks of type 2 diabetes, cardiovascular disease, and obstructive sleep apnoea [4]. Our team can discuss payment plans and dose optimisation to balance clinical outcomes with affordability.

Clinical Evidence: What the Trials Show

The SURMOUNT-1 trial enrolled 2,539 adults with obesity and demonstrated that tirzepatide 15mg once weekly produced an average weight reduction of 22.5% over 72 weeks, compared to 2.4% with placebo [1]. More than half of participants achieved at least 20% weight loss—a threshold previously seen only with bariatric surgery.

Semaglutide's efficacy is supported by the STEP programme, which included over 4,500 participants across multiple trials. STEP 1 showed that 69.1% of patients on semaglutide 2.4mg achieved at least 10% weight loss, versus 12% on placebo [2]. Importantly, participants also experienced improvements in waist circumference, blood pressure, and lipid profiles.

Liraglutide 3.0mg (Saxenda) was evaluated in the SCALE trials, where 63.2% of patients lost at least 5% of their body weight over 56 weeks, compared to 27.1% on placebo [3]. Whilst the magnitude of weight loss is lower than newer agents, Saxenda remains a valuable option for patients who cannot tolerate weekly injections or prefer daily dosing.

Real-world evidence from UK prescribing data confirms that patients who combine GLP-1 therapy with structured lifestyle changes—including dietary modification and increased physical activity—achieve superior long-term outcomes [5]. Our clinical team provides guidance on optimising your nutrition and exercise habits alongside medication.

Long-Term Weight Maintenance

Clinical trials extending beyond one year demonstrate that continued treatment maintains weight loss, whilst discontinuation often leads to gradual weight regain [2][3]. This underscores that GLP-1 medications are long-term therapies rather than short-term solutions. Your prescriber will discuss realistic timelines and strategies for transitioning to maintenance dosing once you reach your target weight.

Managing Side Effects and Safety Considerations

The most common side effects of fat jabs are gastrointestinal: nausea, diarrhoea, constipation, and abdominal discomfort. These symptoms typically emerge during dose escalation and diminish over 4–8 weeks as your body adjusts. Starting at a low dose and gradually increasing—as per MHRA-approved titration schedules—minimises these effects [1][2][3].

Serious but rare adverse events include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other diabetes medications). GLP-1 agonists carry a boxed warning regarding thyroid C-cell tumours observed in rodent studies, and they are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [6].

Our prescribers conduct thorough medical screenings to identify contraindications before approving treatment. You'll receive detailed safety information with your first prescription, including warning signs that require immediate medical attention. If you experience persistent vomiting, severe abdominal pain, or visual changes, contact your GP or NHS 111 immediately.

Pregnancy and breastfeeding are absolute contraindications for all GLP-1 weight loss medications. Women of childbearing age should use reliable contraception during treatment and discontinue the medication at least two months before attempting conception [6]. Our clinical team will discuss these considerations during your consultation.

Drug Interactions and Precautions

GLP-1 medications slow gastric emptying, which can affect the absorption of oral medications including contraceptives, antibiotics, and thyroid hormones. Inform your prescriber of all medications you're taking, including over-the-counter supplements. Patients with a history of diabetic retinopathy should be monitored closely, as rapid weight loss may temporarily worsen retinal conditions [6].

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
4. Ryan, D. H., & Yockey, S. R. (2017). Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. Current Obesity Reports, 6(2), 187–194. https://doi.org/10.1007/s13679-017-0262-y [accessed 13 August 2026]
5. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
6. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, lifestyle modifications, and underlying health conditions.